Posts Tagged ‘pandemic

December 04, 2023
Our Take: AbbVie to acquire ImmunoGen for $10 billion, adding ADC for ovarian cancer to its portfolio
Read More
November 20, 2023
Our Take: Vertex, CRISPR Therapeutics gain first-ever approval of CRISPR-based gene-edited therapy
Read More
November 13, 2023
Our Take: Lilly scores FDA approval of tirzepatide for weight management, intensifying rivalry with Novo Nordisk
Read More
November 06, 2023
Our Take: Drugstore chains claim ‘Pharmageddon’ had minimal impact on stores, say they’re listening to workers
Read More
October 30, 2023
Our Take: Feature: Looking ahead, leading drugmakers will focus on innovation within their existing areas of specialty
Read More
October 23, 2023
Our Take: Henry Ford Health to form joint venture with Ascension Michigan, Aspirus Health advances affiliation plans with St. Luke’s
Read More
October 16, 2023
Our Take: Walgreens to launch virtual care, welcome new CEO as pharmacy staff considers more walkouts
Read More
October 09, 2023
Our Take: Kaiser Permanente to resume contract negotiations this week as more strikes loom
Read More
October 02, 2023
Our Take: Feature: Recent health system partnerships in AI technology
Read More
September 25, 2023
Our Take: CommonSpirit launches PHSO to ‘help providers succeed in value-based care’
Read More
September 18, 2023
Our Take: J&J to rename Janssen Pharmaceuticals as part of its branding update
Read More
September 11, 2023
Our Take: Froedtert Health and ThedaCare move closer to combining, two other mergers are completed
Read More
August 28, 2023
Our Take: CVS launches new biosimilar subsidiary Cordavis
Read More
August 21, 2023
Our Take: Optum-Amedisys deal delayed after DOJ requests more information
Read More

Sign up for Our Take
the weekly strategic brief for Health Care Executives

Contact Darwin Research Group and we will get right back to you.

Reach out to us

Gainey Corporate Center
8777 N Gainey Center Dr, Ste 205
Scottsdale, AZ 85258
(480) 923-0802

Posts Tagged ‘pandemic

Our Take: AbbVie to acquire ImmunoGen for $10 billion, adding ADC for ovarian cancer to its portfolio

Our Take: Vertex, CRISPR Therapeutics gain first-ever approval of CRISPR-based gene-edited therapy

Our Take: Lilly scores FDA approval of tirzepatide for weight management, intensifying rivalry with Novo Nordisk

Our Take: Drugstore chains claim ‘Pharmageddon’ had minimal impact on stores, say they’re listening to workers

Our Take: Feature: Looking ahead, leading drugmakers will focus on innovation within their existing areas of specialty

Our Take: Henry Ford Health to form joint venture with Ascension Michigan, Aspirus Health advances affiliation plans with St. Luke’s

Our Take: Walgreens to launch virtual care, welcome new CEO as pharmacy staff considers more walkouts

Our Take: Kaiser Permanente to resume contract negotiations this week as more strikes loom

Our Take: Feature: Recent health system partnerships in AI technology

Our Take: CommonSpirit launches PHSO to ‘help providers succeed in value-based care’

Our Take: J&J to rename Janssen Pharmaceuticals as part of its branding update

Our Take: Froedtert Health and ThedaCare move closer to combining, two other mergers are completed

Our Take: CVS launches new biosimilar subsidiary Cordavis

Our Take: Optum-Amedisys deal delayed after DOJ requests more information

Sign up for Our Take
the weekly strategic brief for Health Care Executives

share

Contact Darwin Research Group and we will get right back to you.

Reach out to us

Sign up for Our Take
the weekly strategic brief for Health Care Executives

Stay Connected

Posts Tagged ‘pandemic

Sign up for Our Takethe weekly strategic brief for Health Care Executives

share

Contact Darwin Research Group and we will get right back to you.

Reach out to us

Sign up for Our Takethe weekly strategic brief for Health Care Executives

Stay Connected

Sign up for Our Take
the weekly strategic brief for Health Care Executives

Sign up for Our Take
the weekly strategic brief for Health Care Executives